Background: Deleterious mutations in cytosolic leucine-tRNA synthetase (LARS) cause infantile liver failure syndrome, type 1 (ILFS1), a recently recognized, rare autosomal recessive disorder (OMIM151350). Only six families with ILFS1 have been reported in the literature. Patients with ILFS1 are typically diagnosed between 5 and 24 months of age with failure to thrive, developmental delays, encephalopathy, microcytic anemia, and chronic liver dysfunction with recurrent exacerbations following childhood illnesses. Neonatal manifestations of this disorder have not been well documented.
Case Report: We report a premature female newborn with intrauterine growth restriction, failure to thrive, congenital anemia, anasarca, and fulminant liver failure leading to lethal multiple organ failure. Liver failure in this infant was characterized by a disproportionate impairment of liver synthetic function, including severe coagulopathy and hypoalbuminemia without significant defects in liver detoxification or evidence of hepatocellular injury during early phase of the disease. Whole-exome sequencing of child-parent trio identified two inherited missense mutations in LARS in this patient. One, c.1292T>A; p.Val431Asp, has been reported in patients with ILFS1, while the other, c.725C>T; p.Pro242Leu, is novel. Both mutations involve amino acid residues in the highly conserved editing domain of LARS, are predicted to be functionally deleterious, and presumably contribute to the clinical manifestations in this patient.
Conclusion: This is the first case documenting neonatal manifestation of ILFS1, highlighting early, severe, and disproportionate defects in liver synthetic function. Timely diagnosis of ILFS1 is crucial to guide critical clinical management and improve outcomes of this rare and potentially life-threatening disorder.
This is a preview of subscription content, log in to check access.
Bitar R, Thwaites R, Davison S et al (2017) Liver failure in early infancy: aetiology, presentation, and outcome. J Pediatr Gastroenterol Nutr 64:70–75CrossRefGoogle Scholar
Casey J, McGettigan P, Lynam-Lennon N et al (2012) Identification of a mutation in LARS as a novel cause of infantile hepatopathy. Mol Genet Metab 106:351–358CrossRefGoogle Scholar
Casey J, Slattery S, Cotter M et al (2015) Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis 38:1085–1092CrossRefGoogle Scholar
Devictor D, Tissieres P, Durand P et al (2011) Acute liver failure in neonates, infants and children. Expert Rev Gastroenterol Hepatol 5:717–729CrossRefGoogle Scholar
El-Gharbawy A, Sebastian J, Ghaloul-Gonzalez L, Mroczkowski J, Goldstein A, Venkat V, Dobrowolski S, Squires R, Vockley J (2015) LARS mutations in non-Irish travelers: an under-recognized multi-system disorder characterized by infantile hepatopathy during physiological stress. Mitochondrion 24(Suppl):S40–S41CrossRefGoogle Scholar
Han J, Jeong S, Park M et al (2012) Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149:410–424CrossRefGoogle Scholar
Huang Q, Zhou X, Hu Q et al (2014) A bridge between the aminoacylation and editing domains of leucyl-tRNA synthetase is crucial for its synthetic activity. RNA 20:1440–1450CrossRefGoogle Scholar